Pulmonary complications of endocrine and metabolic disorders

Paediatric Respiratory Reviews

Volumn 13, Issue 1, 2012, Pages 23-28

  Milla, Carlos E ^a   Zirbes, Jacquelyn ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Hyperthyroidism; Hypoparathyroidism; Hypothyroidism; Lysosomal storage disorders; Pituitary dysfunction; Pseudohypoaldosteronism

Indexed keywords

ACROMEGALY; CHORIOCARCINOMA; CTFR GENE; CUSHING SYNDROME; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSPNEA; ENAC ALPHA GENE; ENDOCRINE DISEASE; GAUCHER DISEASE; GRANULOSA CELL TUMOR; GRAVES DISEASE; HISTIOCYTOSIS; HUMAN; HUNTER SYNDROME; HYPERALDOSTERONISM; HYPERTHYROIDISM; HYPOTHYROIDISM; LARYNX SPASM; LEYDIG CELL TUMOR; LUNG COMPLICATION; LUNG METASTASIS; LYSOSOME STORAGE DISEASE; MARKER GENE; METABOLIC DISORDER; MUCOPOLYSACCHARIDOSIS; MUTATIONAL ANALYSIS; NIEMANN PICK DISEASE; NKX2.1 GENE; OVARY CARCINOMA; PHEOCHROMOCYTOMA; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PSEUDOHYPERALDOSTERONISM; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; SERTOLI CELL TUMOR; SLEEP APNEA SYNDROME; SPONTANEOUS PNEUMOTHORAX; TITF1 GENE; UPPER RESPIRATORY TRACT OBSTRUCTION; WHEEZING;

CHILD; ENDOCRINE SYSTEM DISEASES; HUMANS; METABOLIC DISEASES; RESPIRATORY TRACT DISEASES;

EID: 84855190777     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.01.004     Document Type: Review

References (75)

1. Hansen L., Prakash U., et al. Pulmonary complications in diabetes mellitus. Mayo Clin Proc 1989, 64(7):791-799.
2. Moutschen M. Alterations in natural immunity and risk of infection in patients with diabetes mellitus. Revue Medicale de Liege 2005, 60(5-6):541-544.
3. Lange P., Groth S., et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989, 2(1):14-19.
4. Sandler M., Bunn A.E., et al. Pulmonary function in young insulin-dependent diabetic subjects. [erratum appears in Chest 1987 May;91(5):797]. Chest 1986, 90(5):670-675.
5. Schnapf B.M., Banks R., et al. Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Resp Dis 1984, 130(5):930-932.
6. Ofulue A.F., Kida K., et al. Experimental diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Resp Dis 1988, 138(2):284-289.
7. Mir S.H., Darzi M.M., et al. Histopathological abnormalities of prolonged alloxan-induced diabetes mellitus in rabbits. International J of Experimental Pathol 2009, 90(1):66-73.
8. Vracko R., Thorning D., et al. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Resp Dis 1979, 120(5):973-983.
9. Kohn R.R., Schnider S.L., et al. Glycosylation of human collagen. Diabetes 1982, 31:5.
10. Ofulue A.F., Thurlbeck W.M., et al. Effects of streptozotocin-induced diabetes on calmodulin and cyclic AMP phosphodiesterase activity in rat lungs. Lung 1982, 160(6):303-310.
11. Hamlin C.R., Kohn R.R., et al. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 1975, 24(10):902-904.
12. Forgiarini L.A., Kretzmann N.A., et al. Experimental diabetes mellitus: oxidative stress and changes in lung structure. Jornal Brasileiro de Pneumologia: Publicacao Oficial Da Sociedade Brasileira de Pneumologia E Tisilogia 2009, 35(8):788-791.
13. Marshall B.C., Butler S.M., et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005, 146(5):681-687.
14. Milla C.E., Warwick W.J., et al. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J of Resp & Crit Care Med 2000, 162(3 Pt 1):891-895.
15. Milla C.E., Billings, et al. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.[see comment]. Diabetes Care 2005, 28(9):2141-2144.
16. Sims E.J., Green M.W., et al. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.[see comment]. Diabetes Care 2005, 28(7):1581-1587.
17. Moran A., Hardin D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.[see comment]. Diabetes Research & Clin Prac 1999, 45(1):61-73.
18. Mimouni F., Miodovnik M., et al. Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr 1988, 113(3):9.
19. Robert M.F., Neff R.K., et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med 1976, 294(7):4.
20. Bourbon J.R., Farrell P.M. Fetal lung development in the diabetic pregnancy. Pediatr Res 1985, 19(3):15.
21. Persson B., Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998, 21(Suppl 2):5.
22. Bennett C.L., Ochs H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin in Pediatr 2001, 13(6):533-538.
23. Bennett C.L., Christie J., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet 2001, 27(1):20-21.
24. Gambineri E., Perroni L., et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy & Clin Immunol 2008, 122(6):1105-1112.
25. Lega J.C., Cottin V., et al. Unusual pulmonary presentation of systemic Langerhans cell histiocytosis. Revue de Medecine Interne 2008, 29(8):669-672.
26. Donnelly P.M., Grunstein R.R., et al. Large lungs and growth hormone: an increased alveolar number?. Eur Respir J 1995, 8:10.
27. Al Lawati N.M., Patel S.R., et al. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Progress in Cardiovasc Dis 2009, 51(4):285-293.
28. Rosenow F., McCarthy V., et al. Sleep apnoea in endocrine diseases. J Sleep Research 1998, 7(1):3-11.
29. Levy S.R., Val Wynne C., et al. Cushing's syndrome in infancy secondary to pituitary adenoma. Am J Dis Child 1982, 136:605-607.
30. van Iperen C.E., Giezen J., et al. Acute dyspnoea resulting from pulmonary oedema as the first sign of phaechromocytoma. Respiration 2001, 68:323-326.
31. Geller D.S., Rodriguez-Soriano J., et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nature Genet 1998, 19:3.
32. Akcay A., Yavuz T., et al. Pseudohypoaldosteronism type I and respiratory distress syndrome. J Pediatr Endocrinol 2002, 15:1557-1561.
33. Thomas C.P., Zhou J., et al. Systemic pseudohypoaldosteronism from deletion of the promoter region of the human Beta epithelial na(+) channel subunit. Am J Resp Cell & Molec Biol 2002, 27(3):314-319.
34. Schaedel C, Marthinsen L., et al. Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha sub-unit of the epithelial sodium channel. J Pediatr 1999, 135:7.
35. Hanukoglu A., Bistritzer T., et al. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 1994, 125(5 Pt 1):752-755.
36. Marthinsen L., Kornfält R., et al. Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Acta Paediatrica 1998, 87:3.
37. MacLaughlin E.F. Pseudohypoaldosteronism and sodium transport. Pediatr Pulmonol 1996, S13:1.
38. Kerem E., Bistritzer T., et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999, 341(3):156-162.
39. Smith D.J., Gaffney E.A., et al. Modelling mucociliary clearance. Resp Physiol& Neurobiol 2008, 163(1-3):178-188.
40. Ladenson P.W., Goldenheim P.D., et al. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med 1988, 84(5):5.
41. Martinez F.M., Bermudez-Gomez M., et al. Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest 1989, 96(5):1059-1063.
42. Lin C.C., Tsan K., et al. The relationship between sleep apnea syndrome and hypothyroidism.[see comment]. Chest 1992, 102(6):1663-1667.
43. Skjodt N.M., Atkar R., et al. Screening for hypothyroidism in sleep apnea. Am J Resp & Critical Care Med 1999, 160(2):732-735.
44. Jha A., Sharma S.K., et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 2006, 7(1):55-61.
45. Siafakas N.M., Salesiotou V., et al. Respiratory muscle strength in hypothyroidism. Chest 1992, 102(1):5.
46. Maquet E., Costagliola S., et al. Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene. J Clin Endocrinol & Metabol 2009, 94(1):197-203.
47. Mosely A.J. Adrenal Activity in Thyroid Dysfunctions: Preliminary Report. Am J Med 1950, 9:259.
48. Squires L., Dolan T.F. Abnormal sweat chloride in auto-immune hypothyroidism. Clin Pediatr 1989, 28(11):535-536.
49. Means M.A., Dobson R.L., et al. Cytological Changes in the Sweat Gland in Hypothyroidism. JAMA 1963, 186:113-115.
50. Pino-Garcia J.M., Garcia-Rio F., et al. Regulation of breathing in hyperthyroidism: relationship to hormonal and metabolic changes. Eur Resp J 1998, 12(2):400-407.
51. Zwillich C.W., Matthay M., et al. Thyrotoxicosis: comparison of effects of thyroid ablation and beta-adrenergic blockade on metabolic rate and ventilatory control. J Clin Endocrinol & Metabol 1978, 46(3):491-500.
52. Irace L., Pergola V.D., et al. Work capacity and oxygen uptake abnormalities in hyperthyroidism. Minerva Cardioangiologica 2006, 54(3):355-362.
53. Otsuka H., Murata M., et al. Exercise performance in children with hyperthyroidism. Acta Paediatrica Japonica 1994, 36(6):678-682.
54. Stockley R.A., Bishop J., et al. Effect of thyrotoxicosis on the reflex hypoxic respiratory drive. Clin Sci & Molec Med 1977, 53(1):93-100.
55. Small D., Gibbons W., et al. Exertional dyspnea and ventilation in hyperthyroidism. Chest 1992, 101(5):1268-1273.
56. Guleria R., Goswami R., et al. Dyspnoea, lung function & respiratory muscle pressures in patients with Graves' disease. Indian J Med Research 1996, 104:299-303.
57. Kahaly G.J., Kampmann C., et al. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 2002, 12(6):473-481.
58. Siafakas N.M., Milona I., et al. Respiratory muscle strength in hyperthyroidism before and after treatment. Am Rev Resp Dis 1992, 146(4):1025-1029.
59. Kendrick A.H., O'Reilly J.F., et al. Lung function and exercise performance in hyperthyroidism before and after treatment. Quarterly J Med 1988, 68(256):615-627.
60. Nabishah B.M., Morat P.B., et al. Cyclic adenosine 3',5'-monophosphate content and bronchial smooth muscle contractility of hyper- and hypothyroid lungs. Clin & Experimental Pharmacol & Physiol 1992, 19(12):839-842.
61. Irwin R.S., Pratter M.R., et al. Airway reactivity and lung function in triiodothyronine-induced thyrotoxicosis. J Applied Physiol 1985, 58(5):1485-1488.
62. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999, 9(7):727-733.
63. Singer J. Neonatal thyrotoxicosis. J Pediatr 1977, 91:5.
64. Oden J., Cheifetz I.M. Neonatal thyrotoxicosis and persistent pulmonary hypertension necessitating extracorporeal life support. Pediatrics 2005, 115(1):e105-e108.
65. Ismail H.M. Reversible pulmonary hypertension and isolated right-sided heart failure associated with hyperthyroidism. J Gen Internal Med 2007, 22(1):148-150.
66. Soroush-Yari A., Burstein S., et al. Pulmonary hypertension in men with thyrotoxicosis. Respiration 2005, 72(1):90-94.
67. Siu C.W., Zhang X.H., et al. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol & Metabol 2007, 92(5):1736-1742.
68. Marvisi M., Brianti M., et al. Hyperthyroidism and pulmonary hypertension. Resp Med 2002, 96(4):215-220.
69. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008, 359:391-403.
70. Wenger D.A., Coppola S., et al. Insights into the diagnosis and treatment of lysosomal storage diseases. Archives of Neurol 2003, 60(3):322-328.
71. Goitein O., Elstein D., et al. Lung involvement and enzyme replacement therapy in Gaucher's disease. QJ Med 2001, 94:407-415.
72. Guillemot N., Troadec C.D., et al. Lung disease in Niemann-Pick disease. Pediatr Pulmonol 2007, 42(12):1207-1214.
73. Barnes P.J. Ceramide lances the lungs. Nature Med 2004, 10(2):130-131.
74. Muenzer J., Wraith J.E., et al. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009, 123(1):19-29.
75. Orchard P.J., Milla C., et al. Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplant 2009, 319.